WENDUINE PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
WENDUINE PHARMA
Largest movements
- Receivables within one year +€132,671
up €132,671 (+88.1%), from €150,577 to €283,249
of which Other amounts receivable: +€92,640
- Tangible fixed assets -€63,917
down €63,917 (-7.3%), from €875,468 to €811,551
of which Plant, machinery and equipment: -€44,044
- Reserves +€74,220
up €74,220 (+7.5%), from €989,335 to €1.1m
of which Distributable reserves: +€74,220
- Trade debts -€15,035
down €15,035 (-10.7%), from €140,006 to €124,972
- Tax, wage and social debts +€13,986
up €13,986 (+53.1%), from €26,333 to €40,319
of which Taxes: +€12,279
- Gross operating margin +€40,316
up €40,316 (+12.3%), from €328,681 to €368,996
- Taxes +€12,675
up €12,675 (+86.7%), from €14,617 to €27,292
- Staff costs +€8,167
up €8,167 (+4.4%), from €185,218 to €193,385
- Financial charges -€4,191
down €4,191 (-79.5%), from €5,272 to €1,080
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,174,275 | €1,247,446 | +€73,171 | +6.2% |
| Fixed assets | 21/28 | €875,473 | €811,556 | -€63,917 | -7.3% |
| Tangible fixed assets | 22/27 | €875,468 | €811,551 | -€63,917 | -7.3% |
| Land and buildings | 22 | €525,742 | €503,775 | -€21,967 | -4.2% |
| Plant, machinery and equipment | 23 | €348,340 | €304,295 | -€44,044 | -12.6% |
| Furniture and vehicles | 24 | €1,386 | €3,481 | +€2,094 | +151% |
| Financial fixed assets | 28 | €5 | €5 | = | 0.0% |
| Current assets | 29/58 | €298,802 | €435,889 | +€137,088 | +45.9% |
| Stocks and contracts in progress | 3 | €142,885 | €147,891 | +€5,006 | +3.5% |
| Stocks | 30/36 | €142,885 | €147,891 | +€5,006 | +3.5% |
| Amounts receivable within one year | 40/41 | €150,577 | €283,249 | +€132,671 | +88.1% |
| Trade receivables | 40 | €98,711 | €138,742 | +€40,031 | +40.6% |
| Other amounts receivable | 41 | €51,866 | €144,507 | +€92,640 | +179% |
| Cash at bank and in hand | 54/58 | €5,339 | €4,749 | -€590 | -11.0% |
| Total equity and liabilities | 10/49 | €1,174,275 | €1,247,446 | +€73,171 | +6.2% |
| Equity | 10/15 | €1,007,935 | €1,082,155 | +€74,220 | +7.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €989,335 | €1,063,555 | +€74,220 | +7.5% |
| Tax-exempt reserves | 132 | €44,318 | €44,318 | = | 0.0% |
| Distributable reserves | 133 | €945,017 | €1,019,237 | +€74,220 | +7.9% |
| Amounts payable | 17/49 | €166,340 | €165,291 | -€1,049 | -0.6% |
| Amounts payable within one year | 42/48 | €166,340 | €165,291 | -€1,049 | -0.6% |
| Trade debts | 44 | €140,006 | €124,972 | -€15,035 | -10.7% |
| Suppliers | 440/4 | €140,006 | €124,972 | -€15,035 | -10.7% |
| Taxes, remuneration and social security | 45 | €26,333 | €40,319 | +€13,986 | +53.1% |
| Taxes | 450/3 | €4,629 | €16,908 | +€12,279 | +265% |
| Remuneration and social security | 454/9 | €21,704 | €23,411 | +€1,707 | +7.9% |
| Non-recurring operating income | 76A | €12,237 | - | -€12,237 | |
| Remuneration, social security and pensions | 62 | €185,218 | €193,385 | +€8,167 | +4.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €71,263 | €71,032 | -€231 | -0.3% |
| Other operating charges | 640/8 | €5,238 | €4,813 | -€426 | -8.1% |
| Gross operating margin | 9900 | €328,681 | €368,996 | +€40,316 | +12.3% |
| Operating profit (loss) | 9901 | €66,962 | €99,767 | +€32,805 | +49.0% |
| Financial income | 75/76B | €1,871 | €2,825 | +€954 | +51.0% |
| Recurring financial income | 75 | €1,871 | €2,825 | +€954 | +51.0% |
| Financial charges | 65/66B | €5,272 | €1,080 | -€4,191 | -79.5% |
| Recurring financial charges | 65 | €5,272 | €1,080 | -€4,191 | -79.5% |
| Profit (loss) for the period before taxes | 9903 | €63,562 | €101,511 | +€37,950 | +59.7% |
| Income taxes | 67/77 | €14,617 | €27,292 | +€12,675 | +86.7% |
| Profit (loss) for the period | 9904 | €48,945 | €74,220 | +€25,274 | +51.6% |
| Profit (loss) for the period to be appropriated | 9905 | €48,945 | €74,220 | +€25,274 | +51.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.